Press Release - Exponential sales growth in 2024
Asfertglobal registers a 20% increase in volume of business, driven by international expansion and strong growth in consolidated markets.
Asfertglobal, a Portuguese multinational specializing in the manufacture of Biofertilization and Biocontrol solutions, ended 2024 with a 20% increase in volume of business. This remarkable performance was driven by expansion in strategic markets such as the United States, with an increase of 70% and Latin America where growth reached 43%.
In addition to its success in these new markets, the company strengthened its presence in already consolidated markets such as Spain and South Africa, with growth of 50% and 45% respectively.
Asfertglobal remains committed to the progress of the agricultural sector, promoting more sustainable practices. In line with this objective, the company has invested significantly in Research and Development (R&D) over the last year, providing farmers with two new products that boost plant health and crop productivity.
New products
This strategy has led to the launch of two new products – Kiplant Solevure and Kiplant Endofit.
Developed using Omics, Big Data and Machine Learning techniques, these new products use exclusive INomics technology, guaranteeing superior performance and optimized results for farmers.
• Kiplant Solevure – Soil prebiotic that regulates the native microbiome and provides essential carbon for beneficial microorganisms.
• Kiplant Endofit – Microbial inoculant with endophytic action that colonizes the surface of plants, promoting a natural competition unfavorable to the development of pathogenic microorganisms.
With significant results and an ongoing commitment to innovative technologies and sustainable practices, Asfertglobal is reinforcing its dedication to promoting more efficient and zero residue agriculture. Its approach, which combines innovation, global expansion and resilience, consolidates the company's position as an example of excellence in the progress of the agricultural sector.
